
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Study reveals how fast weight returns after ending GLP-1 drugs - 2
SpaceX launches Starlink missions in dual-coast spaceflight doubleheader (videos) - 3
Coalition led by Iraqi PM al-Sudani wins parliamentary elections - 4
Are multiverses real? An astrophysicist explains why it depends on how you define ‘real’ - 5
Best Food Truck Cooking: Decision in favor of Your Number one!
'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
World leaders, rights groups react to COP30 climate deal
Viruses aren’t all bad: In the ocean, some help fuel the food web – a new study shows how
Farmers call for French blockades over cow disease cull
Figure out How to Put resources into Lab Precious stones
After toilet and email issues, Artemis II astronauts fire engine to head for the moon
Death toll from floods in Afghanistan rises to 61
A Pompeii site reveals the recipe for Roman concrete. It contradicts a famous architect’s writings
Top 20 Compelling Business Books for Progress













